Two Sides of the Coin: The Patient Experience and the Scientists that Study their Biology
60 minutes
Patients and scientists can experience the arduous trek from drug discovery to treatment from opposite ends. Scientists seek to understand the molecular and cellular basis of a disease to treat or cure a patient population. Meanwhile, patients know the reality of their symptoms and day-to-day limitations. How can we bridge the divide and give scientists the opportunity to step back and hear directly from patients about how their biology affects a person first-hand?
Speakers
Glenda Thomas - Owner at nCeptive, Member of Massachusetts Rare Disease Advisory Council
Michelle Hoarty - Senior Manager, Clinical Science & Biomarker Development, Ra Pharma
Rehan Verjee - Co-founder & CEO, Stealth Start Up
Tracy Antonelli - Beta Thalassemia Patient and Parent